BioChain to Distribute Clinical Genomics' Cancer Test in China
October 31, 2014 at 06:11 AM EDT
BioChain, a diagnostics company with operations in San Francisco and China, has become the exclusive China distributor of Clinical Genomics' colorectal cancer screening technology. Clinical Genomics of Australia has marketed Insure FIT®, a fecal immunochemical test, around the globe since 1994. BioChain, which will run a China trial of the test to qualify for CFDA approval, will attempt to make the test part of China's recently announced Cancer Screening Feasibility Study. More details.... Share this with colleagues: // //